The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Anti-Inflammatory Therapeutics Market Projected To Reach By 2030?
The market for anti-inflammatory therapeutics has shown consistent expansion in recent years. Projections indicate this market will expand from $117.28 billion in 2025 to $122.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.3%. Historically, this growth was driven by factors including the increasing prevalence of arthritis, a rise in inflammatory bowel disease cases, the expansion of hospital pharmacy networks, the uptake of corticosteroids, and the demand for pain management drugs.
The anti-inflammatory therapeutics market size is projected to experience substantial growth in the coming years, with an anticipated expansion to $152.04 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.6%. This expected increase during the forecast period is attributed to several factors, including the development of targeted biologics, the integration of AI in drug discovery, the expansion of online pharmacies, an increasing geriatric population, and a rising focus on personalized medicine. Significant trends foreseen in this period involve personalized anti-inflammatory therapies, an increased adoption of biologic drugs, the development of minimally invasive drug delivery systems, a growth in chronic pain management solutions, and the further expansion of online pharmacy distribution.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp
Which Strong Drivers Are Impacting The Anti-Inflammatory Therapeutics Market Growth?
The escalating occurrence of inflammatory bowel disease is anticipated to fuel expansion within the anti-inflammatory therapeutics market moving ahead. Inflammatory bowel disease (IBD) is defined as a persistent condition characterized by inflammation of the digestive system. Anti-inflammatory treatments are vital for managing Crohn’s disease, effectively diminishing inflammation, alleviating its symptoms, and lowering the necessity for surgical intervention. An illustrative example comes from June 2023 data by Crohn’s and Colitis Canada, a Canadian non-profit, indicating that the number of individuals afflicted with inflammatory bowel disease (IBD) in Canada is projected to reach 470,000 by 2035, a rise from approximately 322,600 in 2023. Consequently, the rising incidence of inflammatory bowel disease is a key factor stimulating the expansion of the anti-inflammatory therapeutics market.
Which Segment Types Are Examined In The Anti-Inflammatory Therapeutics Market Segment Study?
The anti-inflammatory therapeutics market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins
Which Trends Are Guiding The Direction Of The Anti-Inflammatory Therapeutics Market?
Leading firms within the anti-inflammatory therapeutics market are concentrating on creating groundbreaking biologic treatments aimed at enhancing patient results for those suffering from chronic inflammatory ailments. Such sophisticated therapies are formulated to provide precise immune modulation, superior effectiveness, and improved patient tolerance in contrast to traditional approaches like corticosteroids. An example of this is the introduction of Kevzara (sarilumab) in February 2023 by Regeneron Pharmaceuticals Inc., a US-based biotechnology firm, and Sanofi, a France-based pharmaceutical and healthcare enterprise. This product is the inaugural and sole anti-inflammatory biologic endorsed for adult patients suffering from polymyalgia rheumatica (PMR) who exhibit insufficient response to corticosteroids or cannot endure corticosteroid dose reduction. As a novel IL-6 receptor inhibitor, Kevzara offers a more potent and steroid-conserving treatment alternative, thereby addressing a crucial unfulfilled requirement in PMR care and solidifying the market standing of these companies within the anti-inflammatory therapeutics sector.
Which Players Are Part Of The Competitive Landscape Of The Anti-Inflammatory Therapeutics Market?
Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Co. Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
Get The Full Anti-Inflammatory Therapeutics Market Report:
Which Geographic Region Dominates The Anti-Inflammatory Therapeutics Market?
North America was the largest region in the anti-inflammatory therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Anti-Inflammatory Therapeutics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2026, By The Business Research Company
Anti Inflammatory Therapeutics Market Report 2026
Non Steroidal Anti Inflammatory Drugs Market Report 2026
Rare Inflammatory Disease Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model